FAP | ApexOnco - Clinical Trials news and analysis

x

“The insights provided by the analysts are great”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Trial results

1 February 2024

Roche perseveres with FAP

A third discontinuation leaves one anti-FAP project in Roche’s clinical pipeline.

Subscribe to FAP